China Traditional Chinese Medicine Holdings Co. Limited (CHIZF) Research

Operating as an investment holding company, China Traditional Chinese Medicine Holdings Co. Limited (CTCMH) primarily dedicates its efforts within the People's Republic of China. Its core business revolves around the investigation, development, manufacturing, and distribution of both traditional Chinese medicine and a wider array of pharmaceutical products. The company offers a comprehensive product range, which includes granulated medicines, ready-to-use pharmaceuticals, traditional decoction ingredients, and various health-related items. Beyond direct product creation and sales, CTCMH extends its operations to encompass the cultivation and management of Chinese medicinal herb plantations. It also engages in the production of traditional Chinese medicines (TCMs), the wholesale and retail trade of pharmaceutical goods, and the provision of specialized marketing, advertising, and advisory services tailored for TCM. Additionally, the company is involved in property rental services. CTCMH distributes its offerings to both medical institutions and directly to consumers via retail pharmacies. Founded in 1573, the company possesses a rich and extensive history. It adopted its current name, China Traditional Chinese Medicine Holdings Co. Limited, in July 2016, previously operating under the name China Traditional Chinese Medicine Co. Limited. Its corporate headquarters are located in Wan Chai, Hong Kong.

Open China Traditional Chinese Medicine Holdings Co. Limited (CHIZF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.